GCN1 and Alzheimer disease: Interestingly, previously, we demonstrated that miRNAs targeting GCN1 are selectively downregulated in the peripheral blood of patients with amnestic mild cognitive impairment, a pre-disease state of Alzheimer’s disease, indicating that GCN1-mediated quality control may be enhanced in amnestic mild cognitive impairment [140].